From Spark to Inferno: How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making | Ipsos
From Spark to Inferno: How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making | Ipsos

From Spark to Inferno

How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making.

China is emerging as an engine of therapeutic innovation, with its science now setting the pace in some of the most competitive areas of drug development, particularly in oncology.

Landmark deals, rapid early-stage data and a unique clinical ecosystem are reshaping how global companies source innovation, structure partnerships, and plan their oncology portfolios.

Ipsos’ latest white paper unpacks what this shift means for business development, strategy and investment teams.

This Point of View explores how Chinese biopharma innovation is reshaping the rules of engagement in global oncology, and where the next wave of opportunity is likely to emerge. Drawing on pipeline comparisons, deal case studies and ecosystem analysis, it helps decision makers distinguish signal from noise.

In our latest Ipsos white paper, our experts reveal:

  • Examining the landmark deals that acted as catalysts
  • Demonstrating how early data from China can ignite partnerships and global interest
  • Exploring the unique ecosystem that enables this innovation
  • Identifying the strategic challenges and how organisations can navigate this complex environment
     

Download

Related news

  • [Webinar] KEYS: Battle For Attention
    Communication Events replay

    [Webinar] KEYS: Battle For Attention

    In an era dominated by ad-skipping, multi-screening, and media fragmentation, the challenge for today’s marketer is no longer just “Who am I reaching?” but “Am I reaching them at all?"
  • Where is metabolic medicine heading
    Healthcare Events replay

    Where is metabolic medicine heading – and what do you need to know?

    What happens when pipeline promise becomes market reality? During this PBSS webinar, Scott Morano and Roberto Cortese expertly guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next.
  • KEYS: Screen time
    Media Measurement Events replay

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?